{"id":"W2912061124","doi":"10.1182/blood-2018-99-115350","title":"Ruxolitinib for the Treatment of Inadequately Controlled Polycythemia Vera without Splenomegaly: 156-Week Follow-up from the Phase 3 Response-2 Study","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Phlebotomy; Ruxolitinib; Medicine; Polycythemia vera; Clinical endpoint; Myelofibrosis; Internal medicine; Surrogate endpoint; Hematocrit; Gastroenterology; Phases of clinical research; Clinical trial; Bone marrow","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004225459,0.001025354,0.00266292,0.0003132973,0.0006661561,0.001252919,0.0007546865,0.001264142,0.003483317],"category_scores_gemma":[0.001722068,0.0003627059,0.00234207,0.0004148202,0.0004521885,0.000929966,0.0004744882,0.003115863,0.001070723],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006375447,"about_ca_system_score_gemma":0.001040903,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006404833,"about_ca_topic_score_gemma":0.001152752,"domain_scores_codex":[0.9990921,0.0004152621,0.00007869922,0.0001439258,0.0000984971,0.0001714391],"domain_scores_gemma":[0.9984635,0.0002517374,0.0004175101,0.0001939661,0.00012983,0.0005434596],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.8020024,0.03385426,0.0200131,0.00133883,0.003993523,0.0005719933,0.0001809064,0.001925542,0.02354369,0.0002221773,0.01015494,0.1021987],"study_design_scores_gemma":[0.5850114,0.3134361,0.08136977,0.0001934178,0.002954978,0.0007064841,0.00007419097,0.001647308,0.004364718,0.0004664396,0.009697881,0.000077338],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9737569,0.006900082,0.001284662,0.0007975052,0.000254731,0.004650531,0.008232433,0.0001869521,0.003936152],"genre_scores_gemma":[0.9771656,0.002117255,0.001606654,0.001949644,0.0003153116,0.00391565,0.009421698,0.00004556357,0.003462664],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004225459,"threshold_uncertainty_score":0.02234668,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05647221275066861,"score_gpt":0.3435319890380213,"score_spread":0.2870597762873527,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}